Clinical Trials Sponsored by PeaceHealth Laboratories

Total 2222 results

IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Fasting State

India
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

Crohn's Disease

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Rotavirus Infection | Norovirus Infection | Adenoviridae Infection
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

Fasting State

India
Ferozsons Laboratories Ltd.

Unknown

Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.

Chronic Stable Angina

Pakistan
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone (REDWOOD403)

Diabetes Mellitus, Type 2

United States
Oakwood Laboratories, LLC

Completed

Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer

Prostate Cancer

United States
Phenomix
Forest Laboratories

Terminated

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
Phenomix
Forest Laboratories

Terminated

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Type 2 Diabetes Mellitus

United States, Argentina, Chile, Czech Republic, India, Peru, Poland
Phenomix
Forest Laboratories

Terminated

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Type 2 Diabetes Mellitus

United States, Argentina, India, Peru, Poland, Czech Republic
Rovi Pharmaceuticals Laboratories

Completed

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Cancer | Venous Thromboembolism

Spain, Portugal, Romania, Russian Federation
Phenomix
Forest Laboratories

Completed

Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Ukraine, Argentina, Malaysia, India, Romania, Thailand, Philippines, Peru
Romark Laboratories L.C.

Completed

4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C

Chronic Hepatitis C

Egypt
Upsher-Smith Laboratories

Completed

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Postmenopausal Symptoms
Oakwood Laboratories, LLC

Completed

Clinical Trial for Prostate Cancer

Prostate Cancer
Ondine Research Laboratories

Completed

Study of Scaling and Root Planing (SRP) With PerioWave vs. SRP Alone in Chronic Periodontitis

Periodontitis

Canada
Romark Laboratories L.C.

Completed

Study of Nitazoxanide in the Treatment of Amebiasis in Children

Amebiasis

Egypt
Mekos Laboratories AS

Unknown

Quaternium-15, Use Test

Allergic Contact Dermatitis Towards Quaternium-15

Denmark
Mekos Laboratories AS

Completed

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

Allergic Contact Dermatitis

Denmark
Laboratoires Thea

Recruiting

Comparison of the Performance and Safety of T2769 Versus Vismed® Multi in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye

France
Laboratorios Poen

Recruiting

Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety

Ocular Hypertension | Glaucoma, Open-Angle

Argentina
Laboratoires Vivacy

Recruiting

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal) (FaceHyal)

Aging | Aesthetics | Volume Deficiency in the Mid-Face

France
Laboratoires Thea

Completed

Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.

Dry Eye

Bulgaria
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

Estonia
Laboratoires Thea

Completed

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

Healthy Volunteers

United States
Laboratorios Poen

Completed

Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment

Allergic Conjunctivitis

Argentina
Laboratoires Vivacy

Completed

Effectiveness and Safety of STYLAGE® M LIDOCAINE Versus STYLAGE® M in Filling Nasolabial Folds (MLIDOM)

Aging

France
Laboratoires FILLMED

Completed

Evaluation of the Long Term Efficacy and Tolerability of ART FILLER® Volume and Lips (AF2)

Aging
Laboratoires Vivacy

Completed

The Evaluation of Efficacy and Safety of Stylage® XL Lidocaïne for the Restoration and/or Augmentation of Facial Volume (BeautyVolume)

Healthy | Aging

France
Laboratoires FILLMED

Completed

Evaluation of the Efficacy and Safety of an Injectable Hyaluronic Acid-based Filler, Art Filler® Volume: Comparative Single-blind Study of the Non-inferiority Versus Juvéderm® Voluma on the Midface, Temple and Jaw-line and Non-comparative Study on the Chin. (AF3) (AF3)

Aging

France
Laboratoires Thea

Completed

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Age Related Macular Degeneration

France
Vichy Laboratoires

Completed

Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne

Acne

France
Laboratoires Thea

Completed

Efficacy and Tolerability of Blephademodex Wipes

Demodex Blepharitis

Germany
Laboratorios Ordesa

Unknown

Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture (IRENE)

Malnutrition | Hip Fractures

Spain
Laboratoires Vivacy

Completed

The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity (HYDRELA)

Aging

France
Laboratoires Thea

Completed

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Primary Open Angle Glaucoma | Ocular Hypertension

France
Laboratoires URGO

Completed

Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers (CASSIOPEE)

Ulcers, Leg

France
Laboratoires Thea

Completed

Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

Keratoconus

Turkey, Bulgaria, France, Spain
Laboratoires Genévrier

Completed

Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

Vitiligo | Piebaldism

Belgium, France, Italy
Laboratorios Ordesa

Completed

Effect of a New Infant Cereal on Weight Gain (CEOBE)

Infant Development

Spain
Laboratorios Ordesa

Unknown

A Neurocognitive and Immunological Study of a New Formula for Healthy Infants (COGNIS)

Infant Development

Spain
Laboratoires URGO

Unknown

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers (DISCOVERY)

Diabetic Foot Ulcer

Czechia, France, Italy, Poland, Spain, United Kingdom
Laboratoires URGO

Unknown

HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer (HEAL)

Wound
Laboratoires Thea

Completed

Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome

Dry Eye Syndrome

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Open Angle Glaucoma

France
Laboratoires Thea

Terminated

Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye Syndrome

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery

Cataract

France
Laboratoires Thea

Completed

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

Purulent Bacterial Conjunctivitis

France

3

Subscribe